FDA product code PGQ: Cochlear Implant With Combined Electrical Stimulation And Acoustic Amplification

PGQ is the FDA product code for cochlear implant with combined electrical stimulation and acoustic amplification. It is a Class III device, reviewed by the Ear, Nose and Throat panel. Devices under PGQ reach the market by PMA; FDA lists no cleared 510(k)s for it. 2 PMA applications cite this product code. FDA has posted 3 recalls for PGQ devices.

Definition

Intended to provide electric stimulation to the mid to high frequency region of the cochlea and acoustic amplification to the low frequency regions, for patients with residual low frequency hearing sensitivity.

Classification

FieldValue
Device nameCochlear Implant With Combined Electrical Stimulation And Acoustic Amplification
Device classClass III
Review panelEN — Ear, Nose and Throat
Medical specialtyUnknown
Premarket routePMA
ImplantYes

Recalls for PGQ devices

3 product recalls in 1 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2018-10-16.

YearRecalls
20183

HCPCS codes with matching descriptors

Text match between the FDA device name and CMS descriptors, not an official crosswalk:

Frequently asked questions

What is FDA product code PGQ?

PGQ is the FDA product code for cochlear implant with combined electrical stimulation and acoustic amplification. It is a Class III device, reviewed by the Ear, Nose and Throat panel.

What device class is PGQ?

Class III. Typical premarket route: PMA.

Have PGQ devices been recalled?

Yes: 3 product recalls across 1 recall events; the most recent began 2018-10-16.

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Ear, Nose and Throat product codes · FDA product code lookup · 510(k) database search · 510(k) review times